Cover Image
Market Research Report

Vaccines 2016: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments (Influenza, Cervical Cancer, Combinations, Hepatitis, Pneumococcal, MMR, Varicella, Poliovirus, HIB, Others)

Published by Kalorama Information Product code 251887
Published Content info 260 Pages
Immediate Delivery Available
Price
Back to Top
Vaccines 2016: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments (Influenza, Cervical Cancer, Combinations, Hepatitis, Pneumococcal, MMR, Varicella, Poliovirus, HIB, Others)
Published: March 25, 2016 Content info: 260 Pages
Description

‘Vaccines: The World Market’ examines the market for vaccines used in humans to prevent various types of disease. It focuses on commercialized vaccines and developmental vaccines for diseases that are already vaccine-preventable, with a discussion of selected emerging vaccines for diseases that are not currently vaccine-preventable, such as addiction and malaria. Sales estimates for each market segment represent global revenues and are expressed in current dollars. Estimates are provided for the 2013 to 2017 period and forecasts are provided through 2022.

The global market for human vaccines experienced strong growth through 2015. Through 2022, growth will be fueled by continued new product introductions, indication expansions for some products and rising usage, particularly in South America, Europe, India and China. The report provides a comprehensive market summary, including:

  • Sales Growth of Vaccines vs. Pharmaceuticals, 2013-2022
  • World Market for Vaccines by Type, 2013-2022 (Pediatric, Adult)
  • The World Vaccines Market by Vaccine Type, 2013-2022 (Pediatric: Combinations, Hepatitis, HIB, MMR, Pneumococcal, Poliovirus, Varicella, Others; Adult: Cervical Cancer, Hepatitis, Influenza, Pneumococcal, Travel - DT - Misc., Total)
  • The World Vaccines Market by Region, 2013-2022 (U.S., North America / Caribbean, South America, EU, Japan, India, China, ROW, Total)
  • Major Manufacturers' Shares of the World Vaccine Market, 2015
  • 2015 World Vaccines Market Share, by Leading Competitors
  • Major Manufacturer's Shares of the World Pediatric Vaccine Market, 2015
  • Major Manufacturers' Shares of the World Adult Vaccine Market, 2015

A wide variety of vaccine products are currently recommended to immunize children against disease. The report examines the developing and current pediatric preventive vaccines market, including:

  • Selected Pediatric Vaccines in Development, March 2016
  • World Market for Pediatric Vaccines by Type (Hep, HiB, MMR, Combinations, Pneumococcal, Polio, Varicella, Others), 2013-2022
  • Market Share of Pediatric Vaccines by Type, 2015 (Hep, HiB, MMR, Combos, Pneumococcal, Polio, Varicella, Others)
  • Market Share of Pediatric Vaccines, by Type, 2022 (Hep, HiB, MMR, Combos, Pneumococcal, Polio, Varicella, Others)
  • World Market for Pediatric Vaccines by Region (U.S., North America, South America, EU, Japan, India, China, Rest of World), 2013-2022
  • World Pediatric Hepatitis Vaccine Market, 2013-2022
  • World Hib Vaccine Market, 2013-2022
  • World MMR Vaccines Market, 2013-2022
  • World Combination Vaccines Market, 2013-2022
  • World Pediatric Pneumococcal Vaccine Market, 2013-2022
  • World Poliovirus Vaccine Market, 2013-2022
  • World Varicella Vaccine Market, 2013-2022
  • World Pediatric Other Vaccines Market, 2013-2022

Adult immunization is an important, but frequently overlooked, part of patient care. Vaccination programs typically focus on children, yet adults in industrialized countries are more likely to die as a result of vaccine-preventable diseases than are children. The report looks in detail at the adult preventative vaccines market, including:

  • Selected Adult Preventive Vaccines in Development, 2016
  • World Market for Adult Preventive Vaccines by Type (Hepatitis, Influenza, Pneumococcal, Travel/DT/Misc.), 2013-2022
  • Market Share of Adult Vaccines, by Type, 2015 (Cervical Cancer; Hepatitis; Influenza; Pneumococcal; Travel, DT, Misc.)
  • Market Share of Adult Vaccines, by Type, 2022 (Cervical Cancer; Hepatitis; Influenza; Pneumococcal; Travel, DT, Misc.)
  • World Market for Adult Vaccines by Region (U.S., North America, South America, EU, Japan, India, China, Rest of World), 2013-2022
  • World Cervical Cancer Vaccine Market, 2013-2022
  • World Hepatitis Vaccine Market, 2013-2022
  • World Influenza Vaccine Market, 2013-2022
  • World Pneumococcal Vaccine Market, 2013-2022
  • World Travel; Diphtheria-Tetanus; Miscellaneous Vaccines Market, 2013-2022

‘Vaccines: The World Market’ also examines key issues and trends in the global vaccine market today, including product safety and refusal to immunize, obesity, pricing pressure, supply shortages, increasing vaccine development efficiency, and innovations in vaccine delivery systems and production.

The world vaccines market is dominated by several major competitors. The report provides company profiles of these, including:

  • Bavarian Nordic A/S
  • Bharat Biotech
  • Crucell /Johnson & Johnson
  • CSL Limited
  • Emergent Biosolutions
  • GlaxoSmithKline
  • Hawaii Biotech
  • MedImmune
  • Merck & Co., Inc.
  • Mymetics
  • Opexa Therapeutics
  • Pfizer
  • Sanofi Pasteur

Historical information for this report was gathered from a wide variety of published sources including company reports and filings, government documents, legal filings, trade journals, newspapers and business press, analysts' reports and other sources. Interviews with company representatives and other experts were conducted to capture the perspectives from industry participants' point of view and assess trends, and form the basis of the forecasting and competitive analysis.

Table of Contents
Product Code: KLI5948213

Table of Contents

ONE: EXECUTIVE SUMMARY

  • The Global Vaccines Industry
  • Scope and Methodology
  • Overview
  • Pediatric Preventative Vaccines
  • Adult Preventative Vaccines
  • The Market
  • Issues and Trends

TWO: INTRODUCTION TO VACCINES

  • A Brief History: The Development of Vaccines
  • The Immune Response
  • Mechanism of Action
  • Types of Vaccines
  • Attenuated (Weakened) Live Viruses
  • Killed (Inactivated) Viruses
  • Toxoid Vaccines
  • Genetically Engineered/Modified Vaccines
  • Vaccine Approval Process

THREE: PEDIATRIC PREVENTIVE VACCINES

  • Introduction
  • Childhood Immunization in the United States
  • Childhood Immunization Rates
  • Challenges to the Vaccine Delivery System
  • The Effect of U.S. Healthcare Reform
  • The Effect of Addiction
  • Recommended Childhood Immunization Schedule
  • State Immunization Recommendations
  • United Nations Initiatives
  • Pediatric Vaccine Products
  • Addiction
  • BCG
  • Dengue Fever
  • Diphtheria, Tetanus, Pertussis, Hepatitis B and Polio
  • Haemophilus Influenzae Type B
  • Hand, Foot & Mouth Disease
  • Hepatitis A
  • Influenza
  • Measles, Mumps and Rubella
  • Meningococcal Disease
  • Parainfluenza Virus Type 3
  • Pneumococcal Conjugate
  • Rotavirus
  • Respiratory Syncytial Virus
  • Varicella
  • Pediatric Vaccines in Development
  • Cost of Vaccines in the United States
  • The World Market for Pediatric Preventive Vaccines
  • Total Market Size and Forecast
  • Hepatitis Vaccine Market
  • Haemophilus Influenzae Type B Vaccine Market
  • Measles, Mumps and Rubella Vaccines
  • Combination Vaccines Market
  • Pneumococcal Vaccine
  • Poliovirus Vaccine
  • Varicella Vaccines
  • Other Vaccines Market

FOUR: ADULT PREVENTIVE VACCINES

  • Introduction
  • Adult Vaccine-Preventable Diseases: Facts and Figures
  • Global Influenza Surveillance Program
  • U.S. Surveillance
  • Recommendations for Adult Immunizations
  • WHO International Health Regulations
  • Adult Vaccine Products
  • BCG
  • Cervical Cancer
  • Cholera
  • Diphtheria-Tetanus
  • Ebola
  • Hepatitis
  • Influenza
  • Japanese Encephalitis
  • Nosocomial Infections
  • Pneumococcal Disease
  • Rabies
  • Shingles
  • Typhoid Fever
  • Yellow Fever
  • Adult Vaccines in Development
  • The World Market for Adult Preventive Vaccines
  • Total Market Size and Forecast
  • Cervical Cancer Market
  • Hepatitis Market
  • Influenza Vaccine Market
  • Pneumococcal Vaccine Market
  • Travel, DT, and Miscellaneous Vaccine Market

FIVE: VACCINES MARKET SUMMARY

  • Trends Driving the Vaccines Market
  • Market Size and Forecast
  • Vaccine Sales by Region
  • Vaccine Market Competitors
  • Pediatric Vaccines
  • Adult Vaccines

SIX: ISSUES AND TRENDS

  • Vaccine Safety
  • Refusal to Immunize
  • Obesity
  • Post-Licensure Surveillance
  • The Vaccine Injury Compensation Program
  • World Health Organization
  • Other Initiatives
  • The Future of Vaccine Safety
  • Pricing Pressure
  • Vaccine Shortages
  • Preventing Shortages in the Developed Countries
  • Preventing Shortages in Developing Nations
  • Preventing Pandemics
  • U.S. National Vaccine Plan
  • Vaccines and Bioterrorism
  • Overview
  • Project Bioshield Act
  • National Bio and Agro-Defense Facility
  • Vaccine Treatment and Evaluation Units
  • Anthrax
  • Smallpox
  • Stimulating Vaccine Development
  • Global Health Vaccine Center of Innovation
  • Human Vaccines Project
  • Innovations in Vaccine Delivery Systems
  • Mucosal Delivery
  • Intranasal Delivery
  • Vaccine Patches
  • Vaccine Chips and Microneedles
  • Innovations in Vaccine Production
  • Plants
  • Insects
  • Nanoparticle Systems
  • Cloning

SEVEN: COMPANY PROFILES

  • Bavarian Nordic A/S
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial Information
  • Bharat Biotech
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial Information
  • Crucell /Johnson & Johnson
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial Information
  • CSL Limited
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial Information
  • Emergent Biosolutions
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial
  • GlaxoSmithKline
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial Information
  • Hawaii Biotech
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial Information
  • MedImmune
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial Information
  • Merck & Co., Inc
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial Information
  • Mymetics
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial Information
  • Opexa Therapeutics
  • History and Lines of Business
  • Vaccine Products
  • Financial Information
  • Pfizer
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial Information
  • Sanofi Pasteur
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial Information

APPENDIX: COMPANY DIRECTORY

LIST OF EXHIBITS

TWO: INTRODUCTION TO VACCINES

  • Table 2-1: Global Morbidity of Vaccine Preventable Diseases in 1990 vs 2014
  • Figure 2-1: Attenuated Virus Production
  • Table 2-2: Vaccine-Preventable Diseases, March 2016
  • Table 2-3: VAERS Table of Reportable Events Following Vaccination

THREE: PEDIATRIC PREVENTIVE VACCINES

  • Table 3-1: Global Child Immunization Rates for Vaccines Recommended by the WHO, 2015
  • Table 3-2: Immunization Profile of the United States: Population by Age Group,Number of Vaccine-Preventable Diseases Reported by Disease, 1990 - 2014
  • Figure 3-1: National Overdose Death Rates, Number of Deaths from Prescription Drugs, 2001 - 2014
  • Figure 3-2: National Overdose Death Rates, Number of Deaths from Heroin, 2001 - 2014
  • Table 3-3: Marketplace Enrollment as a Share of the Eligible Population, September 2015
  • Table 3-4: U.S. Recommended Immunization Schedule for Children Ages Through 18 Years, 2016
  • Figure 3-3: FluMist Flu Hero
  • Table 3-5: Selected Pediatric Vaccines in Development, March 2016
  • Table 3-6: World Market for Pediatric Vaccines by Type (Hep, HiB, MMR,Combinations, Pneumococcal, Polio, Varicella, Others), 2013-2022 Revenues
  • Figure 3-4: Market Share of Pediatric Vaccines by Type, 2015 (Hep, HiB, MMR,Combos, Pneumococcal, Polio, Varicella, Others)
  • Figure 3-5: Market Share of Pediatric Vaccines, by Type, 2022 (Hep, HiB, MMR,Combos, Pneumococcal, Polio, Varicella, Others)
  • Table 3-7: World Market for Pediatric Vaccines by Region (U.S., North America,South America, EU, Japan, India, China, Rest of World), 2013-2022 Revenues
  • Table 3-8: World Pediatric Hepatitis Vaccine Market, 2013-2022
  • Table 3-9: World Hib Vaccine Market, 2013-2022
  • Table 3-10: World MMR Vaccines Market, 2013-2022
  • Table 3-11: World Combination Vaccines Market, 2013-2022
  • Table 3-12: World Pediatric Pneumococcal Vaccine Market, 2013-2022
  • Table 3-13: World Poliovirus Vaccine Market, 2013-2022
  • Table 3-14: World Varicella Vaccine Market, 2013-2022
  • Table 3-15: World Pediatric Other Vaccines Market, 2013-2022

FOUR: ADULT PREVENTIVE VACCINES

  • Table 4-1: Universal Adult Immunization Schedule, 2016
  • Table 4-2: Summary of Recommendations for Adult Immunization
  • Table 4-3: Initiatives to Require HPV Vaccination by U.S. State, 2016
  • Figure 4-1: U.S. Flu Season Severity from 2002 to 2015
  • Table 4-4: WHO Pandemic Classification Schedule
  • Table 4-5: Selected Adult Preventive Vaccines in Development, 2016
  • Table 4-6: World Market for Adult Preventive Vaccines by Type (Hepatitis,Influenza, Pneumococcal, Travel/DT/Misc.), 2013-2022 Revenues
  • Figure 4-2: Market Share of Adult Vaccines, by Type, 2015 (Cervical Cancer;Hepatitis; Influenza; Pneumococcal; Travel, DT, Misc.)
  • Figure 4-3: Market Share of Adult Vaccines, by Type, 2022 (Cervical Cancer;Hepatitis; Influenza; Pneumococcal; Travel, DT, Misc.)
  • Table 4-7: World Market for Adult Vaccines by Region (U.S., North America,South America, EU, Japan, India, China, Rest of World), 2013-2022 Revenues
  • Table 4-8: World Cervical CancerVaccine Market, 2013-2022
  • Table 4-9: World Hepatitis Vaccine Market, 2013-2022
  • Table 4-10: World Influenza Vaccine Market, 2013-2022
  • Table 4-11: 2015 Estimated Population by Region and Selected Age Group(Africa,Asia, Europe, North America, Oceania, South America, World)
  • Table 4-12: World Pneumococcal Vaccine Market, 2013-2022
  • Table 4-13: World Travel; Diphtheria-Tetanus; Miscellaneous Vaccines Market,2013-2022

FIVE: VACCINES MARKET SUMMARY

  • Figure 5-1: Sales Growth of Vaccines vs. Pharmaceuticals, 2013-2022
  • Figure 5-2: World Market for Vaccines by Type, 2013-2022 (Pediatric,Adult)
  • Table 5-1: The World Vaccines Market by Vaccine Type, 2013-2022(Pediatric:
  • Combinations, Hepatitis, HIB, MMR, Pneumococcal, Poliovirus, Varicella, Others;
  • Adult: Cervical Cancer, Hepatitis, Influenza, Pneumococcal, Travel - DT - Misc.,Total)
  • Figure 5-3: World Market for Vaccines Share by Type, 2013 and 2022 (Pediatric,Adult)
  • Table 5-2: The World Vaccines Market by Region, 2013-2022 (U.S., North America /Caribbean, South America, EU, Japan, India, China, ROW, Total)
  • Table 5-3: Major Manufacturers' Shares of the World Vaccine Market, 2015
  • Figure 5-4: 2015 World Vaccines Market Share, by Leading Competitors
  • Table 5-4: Major Manufacturer's Shares of the World Pediatric Vaccine Market,2015
  • Figure 5-5: Market Share of Pediatric Vaccines Market, 2015
  • Table 5-5: Major Manufacturers' Shares of the World Adult Vaccine Market,2015
  • Figure 5-6: Market Share of Adult Vaccines Market, 2015

SIX: ISSUES AND TRENDS

  • Figure 6-1: Refusal to Vacinate Form
  • Table 6-1: Selected Companies/Laboratories Developing Biodefense Vaccines

SEVEN: COMPANY PROFILES

  • Figure 7-1: Bharat Biotech's Product Pipeline, March 2016
  • Figure 7-2: Sanofi Pasteur's Product Pipeline, March 2016
Back to Top